124
Views
5
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Travellers returning to Sweden with falciparum malaria: Pre-travel advice, behaviour, chemoprophylaxis and diagnostic delay

, , , , , , & show all
Pages 760-765 | Received 09 Feb 2005, Published online: 08 Jul 2009

References

  • Legros F, Danis M, and Eurosurveillance Editorial Board. Surveillance of malaria in European Union Countries. Eurosurveillance 1998;3:45–7.
  • Steffen R, deBernardis C, Banos A. Travel epidemiology: a global perspective. Int J Antimicrob Agents 2003; 21: 89–95
  • Schlagenhauf P, Steffen R, Loutan L. Migrants as a major risk group for imported malaria in European countries. J Travel Med 2003; 10: 106–7
  • Toovey S, Jamieson A. Rolling back malaria: how well is Europe doing? Travel Medicine and Infectious Diseases 2003;1:167–75, URL:URL: http://www.elsevierhealth.com/journals/tmid
  • Jelinek T, Schulte C, Behrens R, Grobusch MP, Coulaud JP, Bisoffi Z, et al. Imported falciparum malaria in Europe: Sentinel surveillance data from the European Network on surveillance of imported infectious diseases. Clin Inf Dis 2002; 34: 572–6
  • Hervius Askling H, Nilsson J, Tegnell A, Janzon R, Ekdahl K. Malaria risk in travellers. Emerg Infect Dis 2005; 11: 436–41
  • Jansson A, Arneborn M, Ekdahl K. Sensitivity of the Swedish statutory surveillance system for communicable diseases 1998–2002, assessed by the capture-recapture method. Epidemiol Infect (in press).
  • National guidelines for malaria prophylaxis 2002. Swedish Institute for Infectious Disease Control (SMI) (in Swedish.) URL:URL: http://www.smittskyddsinstitutet.se.
  • Philips-Howard PA, Radalowicz A, Mitchell J, Bradely DJ. Risk of malaria in British residents returning from malarial areas. Br Med J 1990; 300: 499–503
  • Muehlberger N, Jelinek T, Schlipkoeter U, Sonnenburg FV, Nothdurft HD. Effectiveness of chemoprophylaxis and other determinants of malaria in travellers to Kenya. Trop Med Int Health 1998; 5: 357–63
  • Mölle I, Christensen KL, Hansen PS, Dragsted UB, Aarup M, Buhl MR. Use of medical chemoprophylaxis and antimosquito precautions in Danish malaria patients and their travelling companions. J Travel Med 2000; 7: 253–8
  • Lobel HO, Baker MA, Gras FA, Stennies GM, Meerburg P, Hiemstra E, et al. Use of malaria prevention measures by North American and European travellers to East Africa. J Travel Med 2001; 8: 167–72
  • Behrens RH, Taylor RB, Pryce DI, Low AS. Chemoprophylaxis compliance in travellers with malaria. J Travel Med 1998; 5: 92–4
  • Laver SM, Wetzels J, Behrens RH. Knowledge of malaria, risk perception and compliance with prophylaxis and personal environmental preventive measures in travellers exiting Zimbabwe from Harare and Victoria Falls International Airport. J Travel Med 2001; 8: 298–303
  • National Cooperation of Swedish Pharmacies (Apoteket AB). Statistics of prescribed mefloquine and proguanil 1994–2001.
  • Palmer KJ, Holliday SM, Brogden RN. Mefloquine. A review of its antimalarial activity, pharmacokinetic properties and therapeutic efficacy. Drugs 1993; 45: 430–75
  • Notification data from Swedish Institute of Infectious Diseases Control. URL:URL: http://www.smittskyddsinstitutet.se.
  • van Herck K, van Damme P, Castelli F, Zuckerman J, Nothdurft H, Dahlgren AL, et al. Knowledge, attitudes and practices in travel related infectious diseases; the European airport survey. J Travel Med 2004; 11: 3–8

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.